The largest database of trusted experimental protocols

7 protocols using istradefylline

1

Radioligand Binding Assay for Adenosine Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reagents were commercially available and purchased from various manufacturers. Radioligands [3H]DPCPX (120 Ci/mmol) and [3H]NECA (27.1 Ci/mmol) were obtained from PerkinElmer. Adenosine deaminase from bovine spleen (157 units/mg, 5.9 mg/ml, or 130 units/mg, 6.8 mg/ml), CPA, DPCPX, istradefylline, caffeine and anhydrous magnesium chloride (MgCl2) were all obtained from Sigma-Aldrich. Radioactivity was counted by a PerkinElmer Tri-CARB 2810 TR liquid scintillation analyser.
+ Open protocol
+ Expand
2

Evaluation of Adenosine Receptor Modulators

Check if the same lab product or an alternative is used in the 5 most similar protocols
PSB1115 was purchased from Santa Cruz Biotechnology, Inc (Santa Cruz, CA). Methylcellulose, ibudilast and rolipram were obtained from Wako Pure Chemical Industries (Osaka, Japan). Medetomidine chloride (Domitor®) and butorphanol tartrate (Vetorphale®) were obtained from Meiji Seika Pharma Co., Ltd. (Tokyo, Japan) and midazolam was purchased from SANDOZ (Tokyo, Japan). Istradefylline and theophylline were purchased from Sigma (St. Louis, MO). Cilostazol and aminophylline were obtained from LKT laboratories, Inc. (St Paul, MN). MRS-1754 and BAY60-6583 were from Tocris Bioscience (Bristol, UK) and 1,3-dipropyl-8-cyclopentylxanthine (DCPCX), ZM241385 and CGS21680 were from Abcam (Cambridge, UK). ICR mice (5- or 6-week-old males, 28–33 g), primiparous late pregnant Wistar female rats and normal male Wistar rats (4- or 5-week-old, 150–250 g) were obtained from Charles River Laboratories Japan (Yokohama, Japan). The animals were housed under conditions of controlled temperature (22–24 °C) and illumination (12-h light cycle) conditions for 1 or 2 weeks before experiments. The experiments and procedures described here were performed in accordance with the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the National Institutes of Health, and were approved by the Animal Care Committees of Keio University and St. Marianna University.
+ Open protocol
+ Expand
3

Targeted Phrenic Neuron Depletion and Rescue

Check if the same lab product or an alternative is used in the 5 most similar protocols
CtB-Saporin (50 μg, Catalog No: IT-14, Advanced Targeting Systems, San Diego, CA) was dissolved in 80 μl phosphate buffered saline (PBS) and administered intrapleurally to target phrenic motor neurons (25 μg per side) using 50 μl Hamilton syringes having semi-blunt needles of 23-gauge and 6 mm length through the fifth intercostal space anterior axillary line (Mantilla et al., 2009 (link)). Additionally, 50 μg CtB (Catalog No: 227039, EMD Millipore, Billerica, MA, USA) was dissolved in 25 μl sterile water and injected intrapleurally (12.5 μl on each side) to label the spared phrenic motor neurons.
Rats were administered with A2a receptor antagonist starting 36 hours after CtB-Saporin injections, until 6 hours before perfusion at day 5 or 24 hours before EMG recordings (to minimize acute effects of the drug on recordings) and subsequent perfusion. KW6002 (Istradefylline, Sigma-Aldrich) is a selective, blood-brain-barrier-penetrable A2a receptor antagonist (Yang et al., 2007 (link)). KW6002 was dissolved in DMSO (37°C) at 9.3 mg/ml concentration, sonicated, aliquoted and stored at 4°C in dark. Prior to use, KW6002 was re-warmed and administered intraperitoneally twice daily at a dose of 0.5 mg/kg (1.0 mg/kg per day total). The volume of DMSO administered to the vehicle rats was also normalized to body weight (~17–20 μl DMSO per injection, ~50 μl/kg).
+ Open protocol
+ Expand
4

Synergistic Effects of Adenosine Antagonists

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following substances were used: DPCPX (8–cyclopentyl–1,3–dipropylxanthine, Sigma–Aldrich, Poznań, Poland), istradefylline (KW–6002, (E)–8–(3,4–dimethoxystyryl)– 1,3–diethyl–7–methylxanthine, Sigma–Aldrich, Poznań, Poland), magnesium hydroaspartate (Farmapol, Poznań, Poland), and zinc hydroaspartate (Farmapol, Poznań, Poland). DPCPX (1 mg/kg) and istradefylline (0.5 mg/kg) were suspended in a 0.9% saline with Tween 80 (1%) (POCH, Gliwice, Poland), whereas magnesium and zinc hydroaspartate (10 mg/kg and 2.5 mg/kg, calculated as pure magnesium or zinc ions, respectively) were dissolved in 0.9% saline. DPCPX and magnesium hydroaspartate were injected intraperitoneally (i.p.) 30 min, while istradefylline was administered orally (p.o.) and zinc hydroaspartate i.p. 60 min before behavioural testing. Animals from control group were given 0.9% saline. All liquid dosage forms were prepared immediately prior to the experiments and they were administered in a volume of 0.01 mL/g.
The treatment schedules and subtherapeutic doses of DPCPX, Mg2+ and Zn2+ were chosen on the basis of our previous projects [30 (link),31 (link)], whereas of istradefylline were selected on the basis of literature data [105 (link)] and then confirmed in preliminary studies carried out in our laboratory.
+ Open protocol
+ Expand
5

Age-related Istradefylline Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drug solution was made by dissolving istradefylline (Sigma Aldrich, St. Louis, MO, USA) in 2% DMSO and 0.9% saline, then, aliquoted and stored at −20 °C. istradefylline was injected to wild-type C57BL/6J mice intraperitoneally once a week at a dose of 1 mg/kg, commencing at the age of 6 months until the age of 12 months. An equivalent volume of the drug vehicle solution was administered by intraperitoneal injection to the control group of mice once a week.
+ Open protocol
+ Expand
6

Pharmacological Evaluation of Selenium-Mediated Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sodium selenite (Se), DPCPX (8-cyclopentyl-1,3-dipropylxanthine), istradefylline (IST, (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine), and imipramine hydrochloride (IMI) were purchased from Sigma-Aldrich (Poznań, Polska). Se was dissolved in 0.9% NaCl and administered intraperitioneally (i.p.) 30 min prior behavioral testing at doses of 0.125, 0.25, 0.5, and 1.0 mg/kg, which refers to 0.056, 0.1125, 0.225, and 0.45 mg/kg of pure selenium, respectively. DPCPX and IST were suspended in 1% solution of Tween 80 (POCH, Gliwice, Polska) in saline (0.9% NaCl). DPCPX was injected i.p at a dose of 1 mg/kg, while IST was administered per os (p.o.) at a dose of 0.5 mg/kg 60 min before the experiment. IMI (30 mg/kg), used as a reference drug (a positive control group) in Se dose-effect studies, was dissolved in 0.9% NaCl and injected i.p. 60 min before behavioral studies. The control group received 0.9% NaCl at the respective time prior to the experiment. All solutions/suspensions were prepared immediately before behavioral tests and administered in a volume of 0.01 mL/g body weight. Each experimental group consisted of 10 mice, randomly assigned prior to administration of a tested substance.
+ Open protocol
+ Expand
7

Adenosine Regulation of Splenic Lymphocyte Interactions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Splenic lymphocytes were collected by lyzing tissue in a Dounce homogenizer, followed by layering over Ficoll Paque (GE health care, Chicago, IL, USA), as described previously (21) .
Balb/c splenic lymphocytes (3 × 10 6 ) were mixed with SJL/J splenic lymphocytes (3 × 10 6 ) in 500 µL of DMEM medium containing 10% FCS, 100 U/ml penicillin, 100 µg/mL streptomycin, 2 mM L-glutamine, 1 mM sodium pyruvate, and 50 µM 2-mercaptoethanol (D10 medium) in 24 well plates in the presence of adenosine (0-1 mM) (Sigma, St. Louis, MO, USA); in the presence of each adenosine receptor agonist (0-10 µM) (A1R: 2-Chloro-N6-cyclopentyladenosine (CCPA), Tocris, Bristol, UK; A2aR: PSB0777, Tocris; A2bR: BAY 60-6583, Tocris; A3R: HEMADO, Tocris); in the presence of A2aR antagonist (0-1 nM) (Istradefylline, Sigma) plus adenosine (100 µM); in the presence of an adenyl cyclase inhibitor (0-1 µM) (MDL-12330A, Enzo Life Sciences, Farmingdale, NY, USA) or a protein kinase A inhibitor (0-1 µM) (H-89, Tocris) plus adenosine (100 µM) to inhibit A2aR signaling; or in the presence of a CD39 inhibitor (0-1 µM) (ARL67156, Tocris) or a CD73 inhibitor (0-1 µM) (adenosine 5'-(α, β-methylene) diphosphate (AMP-CP; Tocris) plus ATP (100 µM) (GE healthcare). After mixing, the plates were incubated for 7 days at 37°C. The supernatants were collected for use in cytokine ELISAs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!